Tag:

Gilead Sciences

Gilead to buy Arcellx in $7.8B deal

Gilead Sciences said on Monday it will acquire cancer therapy developer Arcellx in a deal valuing the company at an implied equity value of $7.8 billion.

23 Feb 2026-15:40
Gilead announces $11 billion in new investments in US

07 May 2025-22:56
Gilead, LEO Pharma partner to develop programs for inflammatory diseases

11 Jan 2025-23:47

Prev Next

News.az